Paper30032142
MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling.
Chen X and 4 others. Cell Physiol Biochem, 2018. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling. Papers, record 30032142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30032142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Wnt-5a Protein | Major topic |
| 3' Untranslated Regions | |
| Antagomirs | |
| Antineoplastic Agents | |
| Apoptosis | |
| Base Sequence | |
| Cell Line, Tumor | |
| Cisplatin | |
| Databases, Genetic | |
| Glycogen Synthase Kinase 3 beta | |
| Humans | |
| Phosphorylation | |
| Sequence Alignment | |
| Survival Rate | |
| Wnt Signaling Pathway | |
| beta Catenin |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42543381 | Cancer drug response and resistance: molecular mechanisms and combating strategies. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42543381 | PubMed |
| 41545904 | Particulate matter 2.5 promotes bladder cancer cell migration and invasion through the crosstalk between integrin-mediated MAPK/ERK and Wnt/β-catenin pathways. | Part Fibre Toxicol | 2026 | https://conductscience.org/library/papers/41545904 | PubMed |
| 40517336 | β-catenin as a key regulator of the cisplatin response in tumor cells. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40517336 | PubMed |
| 39883227 | Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment. | Med Oncol | 2025 | https://conductscience.org/library/papers/39883227 | PubMed |
| 37950151 | Circular RNA ZNF800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37950151 | PubMed |
| 35363256 | miR-374a-5p regulates inflammatory genes and monocyte function in patients with inflammatory bowel disease. | J Exp Med | 2022 | https://conductscience.org/library/papers/35363256 | PubMed |
| 33928018 | Circ-ZFR Promotes Progression of Bladder Cancer by Upregulating WNT5A Via Sponging miR-545 and miR-1270. | Front Oncol | 2020 | https://conductscience.org/library/papers/33928018 | PubMed |
| 33216248 | MicroRNAs and target molecules in bladder cancer. | Med Oncol | 2020 | https://conductscience.org/library/papers/33216248 | PubMed |
| 32968625 | MicroRNA-374 is a potential diagnostic biomarker for atherosclerosis and regulates the proliferation and migration of vascular smooth muscle cells. | Cardiovasc Diagn Ther | 2020 | https://conductscience.org/library/papers/32968625 | PubMed |
| 32905529 | Estrogen receptor-β signaling induces cisplatin resistance in bladder cancer. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/32905529 | PubMed |
| 32855660 | MicroRNA-652 promotes cell proliferation and osteosarcoma invasion by directly targeting KLF9. | Exp Ther Med | 2020 | https://conductscience.org/library/papers/32855660 | PubMed |
| 31963556 | Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer. | Cells | 2020 | https://conductscience.org/library/papers/31963556 | PubMed |
| 31322232 | Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma. | Oncol Rep | 2019 | https://conductscience.org/library/papers/31322232 | PubMed |
| 31137841 | Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31137841 | PubMed |
| 31002361 | Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway. | Oncol Rep | 2019 | https://conductscience.org/library/papers/31002361 | PubMed |
| 30803356 | MicroRNA-374a Governs Aggressive Cell Behaviors of Glioma by Targeting Prokineticin 2. | Technol Cancer Res Treat | 2019 | https://conductscience.org/library/papers/30803356 | PubMed |
| 30588009 | miRNA-641 inhibits the proliferation, migration, and invasion and induces apoptosis of cervical cancer cells by directly targeting ZEB1. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30588009 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| GSK3B | 2932 | PubTator's text mining | https://conductscience.org/library/genes/2932 | NCBI Gene |
| MIR374A | 442919 | PubTator's text mining | https://conductscience.org/library/genes/442919 | NCBI Gene |
| WNT5A | 7474 | PubTator's text mining | https://conductscience.org/library/genes/7474 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30032142
GET https://conductscience.org/api/papers/v1/30032142/authors